The activated Notch1 signal pathway is associated with gastric cancer progression through cyclooxygenase-2

Cancer Research

Volumn 69, Issue 12, 2009, Pages 5039-5048

  Yeh, Tien Shun ^a,b   Wu, Chew N ^a,c   Hsu, Kai Wen ^a,b   Liao, Wan Jung ^a   Yang, Min Chieh ^a   Li, Anna Fen Yau ^a   Wang, An Ming ^a   Kuo, Min Liang ^d   Chi, Chin Wen ^a,c  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; C PROMOTER BINDING FACTOR 1; CYCLOOXYGENASE 2; JAGGED1; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NOTCH1 RECEPTOR; PROSTAGLANDIN E2; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER SURVIVAL; CANCER TISSUE; CELL MIGRATION; COLONY FORMING UNIT; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; STOMACH ADENOCARCINOMA; STOMACH CANCER; TUMOR XENOGRAFT;

ADENOCARCINOMA; AGED; BASE SEQUENCE; CALCIUM-BINDING PROTEINS; CELL LINE, TUMOR; CYCLOOXYGENASE 2; DISEASE PROGRESSION; DNA PRIMERS; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; RECEPTOR, NOTCH1; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS;

EID: 67449168389     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-4021     Document Type: Article

References (50)

1. Leong KG, Karsan A. Recent insights into the role of Notch signaling in tumorigenesis. Blood 2006;107:2223-2233 (Pubitemid 43345539)
2. Koch U, Radtke F. Notch and cancer: a double-edged sword. Cell Mol Life Sci 2007;64:2746-2762 (Pubitemid 351152259)
3. Radtke F, Raj K. The role of Notch in tumorigenesis: oncogene or tumour suppressor? Nat Rev Cancer 2003;3:756-767
4. Executive Yuan. Taiwan area: death rate of ten leading sites of malignant neoplasms. Taiwan: Department of Health, Executive Yuan; 2006. p. 160-173
5. Terry M, Gaudet M, Gammon M. The epidemiology of gastric cancer. Semin Radiat Oncol 2002;12:111-127 (Pubitemid 34522348)
6. Ushijima T, Sasako M. Focus on gastric cancer. Cancer Cell 2004;5:121-125 (Pubitemid 38283798)
7. Gonzalez C, Sala N, Capella G. Genetic susceptibility and gastric cancer risk. Int J Cancer 2002;100:249-260 (Pubitemid 34728981)
8. Zheng L, Wang L, Ajani J, Xie K. Molecular basis of gastric cancer development and progression. Gastric Cancer 2004;7:61-77. (Pubitemid 38899656)
9. El-Rifai W, Powell S. Molecular biology of gastric cancer. Semin Radiat Oncol 2002;12:128-140 (Pubitemid 34522349)
10. Watson SA, Grabowska AM, El-Zaatari M, Takhar A. Gastrin-active participant or bystander in gastric carcinogenesis? Nat Rev Cancer 2006;6:936-946
11. Smith M, Hold G, Tahara E, El-Omar E. Cellular and molecular aspects of gastric cancer. World J Gastroenterol 2006;12:2979-2990 (Pubitemid 43811073)
12. Ristimäki A, Honkanen N, Jänkälä H, Sipponen P, Härkönen M. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res 1997;57:1276-1280 (Pubitemid 27152551)
13. Uefuji K, Ichikura T, Mochizuki H, Shinomiya N. Expression of cyclooxygenase-2 protein in gastric adenocarcinoma. J Surgical Oncol 1998;69:168-172 (Pubitemid 28549893)
14. Yamamoto H, Itoh F, Fukushima H, Hinoda Y, Imai K. Overexpression of cyclooxygenase-2 protein is less frequent in gastric cancers with microsatellite instability. Int J Cancer 1999;84:400-403 (Pubitemid 29337127)
15. Lim HY, Joo HJ, Choi JH, et al. Increased expression of cyclooxygenase-2 protein in human gastric carcinoma. Clin Cancer Res 2000;6:519-525 (Pubitemid 30111473)
16. Ohno R, Yoshinaga K, Fujita T, et al. Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma. Cancer 2001;91:1876-1881 (Pubitemid 32424114)
17. Shi H, Xu J, Hu N, Xie H. Prognostic significance of expression of cyclooxygenase-2 and vascular endothelial growth factor in human gastric carcinoma. World J Gastroenterol 2003;9:1421-1426 (Pubitemid 36992325)
18. Murata H, Kawano S, Tsuji S, et al. Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma. Am J Gastroenterol 1999;94:451-455 (Pubitemid 29084668)
19. Hu P, Yu J, Zeng Z, et al. Chemoprevention of gastric cancer by celecoxib in rats. Gut 2004;53:195-200. (Pubitemid 38125505)
20. Chen JH, Wu CW, Kao HL, et al. Effects of COX-2 inhibitor on growth of human gastric cancer cells and its relation to hepatocyte growth factor. Cancer Lett 2006;239:263-270 (Pubitemid 43974872)
21. Lee D, Moss S. COX-2 inhibition and the prevention of gastric cancer. Digestion 2006;74:184-186 (Pubitemid 46622788)
22. Jiang X, Wong B. Cyclooxygenase-2 inhibition and gastric cancer. Curr Pharm Des 2003;9:2281-2288 (Pubitemid 37142441)
23. Fujimura T, Ohta T, Oyama K, Miyashita T, Miwa K. Role of cyclooxygenase-2 in the carcinogenesis of gastrointestinal tract cancers: a review and report of personal experience. World J Gastroenterol 2006;12:1336-1345
24. Saukkonen K, Tomasetto C, Narko K, Rio M, Ristimäki A. Cyclooxygenase-2 expression and effect of celecoxib in gastric adenomas of trefoil factor 1-deficient mice. Cancer Res 2003;63:3032-3036 (Pubitemid 36735846)
25. Sander GR, Powell BC. Expression of Notch receptors and ligands in the adult gut. J Histochem Cytochem 2004;52:509-516 (Pubitemid 38420385)
26. Katoh M, Katoh M. Notch ligand, JAG1, is evolutionarily conserved target of canonical WNT signaling pathway in progenitor cells. Int J Mol Med 2006;17:681-685
27. Sekine A, Akiyama Y, Yanagihara K, Yuasa Y. Hath1 up-regulates gastric mucin gene expression in gastric cells. Biochem Biophys Res Commun 2006;344:1166-1171
28. Katoh M. Dysregulation of stem cell signaling network due to germline mutation, SNP, Helicobacter pylori infection, epigenetic change and genetic alteration in gastric cancer. Cancer Biol Ther 2007;6:832-839 (Pubitemid 351574970)
29. Lowy AM, Clements WM, Bishop J, et al. β-Catenin/Wnt signaling regulates expression of the membrane type 3 matrix metalloproteinase in gastric cancer. Cancer Res 2006;66:4734-4741
30. Nicolas M, Wolfer A, Raj K, et al. Notch1 functions as a tumor suppressor in mouse skin. Nat Genet 2003;33:416-421 (Pubitemid 36278861)
31. Yeh TS, Lin YM, Hsieh RH, Tseng MJ, et al. Association of transcription factor YY1 with the high molecular weight Notch complex suppresses the transactivation activity of Notch. J Biol Chem 2003;278:41963-41969 (Pubitemid 37310459)
32. Hsu KW, Hsieh RH, Lee YHW, et al. The activated Notch1 receptor cooperates with α-enolase and MBP-1 in modulating c-myc activity. Mol Cell Biol 2008;28:4829-4842
33. Chiang Y, Lo C, Chen Y, et al. Ethyl caffeate suppresses NF-κB activation and its downstream inflammatory mediators, iNOS, COX-2, and PGE2 in vitro or in mouse skin. Br J Pharmacol 2005;146:352-363 (Pubitemid 41486677)
34. Jin L, Meng C, Han S, et al. A study on production of monoclonal anti-bodies using SC-M1 cells as immunogen. Med Sci 1987;8:17-25.
35. Liao WR, Hsieh RH, Hsu KW, et al. The CBF1-independent Notch1 signal pathway activates human c-myc expression partially via transcription factor YY1. Carcinogenesis 2007;28:1867-1876 (Pubitemid 47500597)
36. Wang AM, Ku HH, Liang YC, Chen YC, Hwu YM, Yeh TS. The autonomous Notch signal pathway is activated by baicalin and baicalein but is suppressed by niclosamide in K562 cells. J Cell Biochem 2009;106:682-692
37. deMoraes E, Dar N, deMoura Gallo C,Hainaut P. Cross-talks between cyclooxygenase-2 and tumor suppressor protein p53: balancing life and death during inflammatory stress and carcinogenesis. Inter J Cancer 2007;121:929-937
38. Wang D, Mann J, DuBois R. WNT and cyclooxygenase-2 cross-talk accelerates adenoma growth. Cell Cycle 2004;3:1512-1515 (Pubitemid 40521402)
39. Lim JW, Kim H, Kim KH. Nuclear factor-κB regulates cyclooxygenase-2 expression and cell proliferation in human gastric cancer cells. Lab Invest 2001;81:349-360 (Pubitemid 32245067)
40. Espinosa L, Ingles-Esteve J, Robert-Moreno A, Bigas A. IκBα and p65 regulate the cytoplasmic shuttling of nuclear corepressors: cross-talk between Notch and NFκB pathways. Mol Biol Cell 2003;14:491-502. (Pubitemid 36237011)
41. Timmerman LA, Grego-Bessa J, Raya A, et al. Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. Genes Dev 2004;18:99-115. (Pubitemid 38090691)
42. Zavadil J, Cermak L, Soto-Nieves N, Böttinger E. Integration of TGF-β/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO J 2004;23:1155-1165 (Pubitemid 38436879)
43. Sahlgren C, Gustafsson MV, Jin S, Poellinger L, Lendahl U. Notch signaling mediates hypoxia-induced tumor cell migration and invasion. Proc Natl Acad Sci U S A 2008;105:6392-6397 (Pubitemid 351758356)
44. Leong KG, Niessen K, Kulic I, et al. Jagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through Slug-induced repression of E-cadherin. J Exp Med 2007;204:2935-2948 (Pubitemid 350179562)
45. Wang T, Holt CM, Xu C, et al. Notch3 activation modulates cell growth behaviour and cross-talk to Wnt/TCF signalling pathway. Cell Signal 2007;19:2458-2467 (Pubitemid 47531927)
46. Yang Z, Zhang X, Gang H, et al. Up-regulation of gastric cancer cell invasion by Twist is accompanied by N-cadherin and fibronectin expression. Biochem Biophys Res Commun 2007;358:925-930 (Pubitemid 46802478)
47. Xu H, Izon DJ, Loftin C, Spain LM. The COX-2 inhibitor NS-398 causes T-cell developmental disruptions independent of COX-2 enzyme inhibition. Cell Immunol 2001;214:184-193 (Pubitemid 34499472)
48. Li S, Tong Q, Zhang W, Wang Q, Chen Z, Wu Q. Mechanism of growth inhibitory effects of cyclooxygenase-2 inhibitor-NS398 on cancer cells. Cancer Invest 2008;26:333-337 (Pubitemid 351601387)
49. Rizzo P, Osipo C, Foreman K, Golde T, Osborne B, Miele L. Rational targeting of Notch signaling in cancer. Oncogene 2008;27:5124-5131
50. Katoh M, Katoh M. Notch signaling in gastrointestinal tract (review). Int J Oncol 2007;30:247-251